United States
North America · Washington, D.C. · USD ($)
Buy a defined outcome
Get a reviewed United States market-entry package
Market Entry Sprint from $2,500 · Strategy Session $500 · Pathway Brief $1,800. Professional review required before business use. No patient data on public forms.
Economic Snapshot
Population
335 million
U.S. Census Bureau · 2023
GDP
$27.4 trillion
World Bank · 2023
GDP per Capita
$82,000
World Bank · 2023
Healthcare Economics
Health Expenditure (% GDP)
17.3% of GDP
CMS National Health Expenditure Accounts · 2022
Health Spending / Capita
$13,493 per year
CMS National Health Expenditure Accounts · 2022
Public Funding Share
~49% (Medicare, Medicaid, VA, CHIP)
CMS National Health Expenditure Accounts · 2022
Country Details
Region
North America
Capital
Washington, D.C.
Currency
USD ($)
Timezone
UTC−5 to UTC−10 (multiple zones)
Languages
English
🚀 Market Opportunities
The US is the world's largest and most lucrative medical device market at ~$180B, and FDA clearance is a global quality signal that opens doors to investors, distributors, and secondary markets. The shift to value-based care is driving demand for connected devices, remote patient monitoring, and AI-powered diagnostics. FDA's Breakthrough Device Designation offers an accelerated pathway for truly innovative technologies. The large aging population (65+ growing rapidly), high prevalence of chronic disease, and premium willingness-to-pay make this the highest-revenue opportunity for any medical device manufacturer globally.